NCT03534648 - Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

July 16, 2018

Study Completion Date

August 29, 2018

Conditions

Healthy

Interventions

DRUG

PF-06865571 administered Day 7-14

PF-06865571 administered Q12hr on Days 7-14

DRUG

PF-06865571 administered Day 1-14

PF-06865571 administered Q12hr on Day 7-14

DRUG

PF-05221304 administered Day 1-14

PF-05221304 administered Q12hr on Days 1-14

DRUG

PF-05221304 administered Day 7-14

PF-05221304 administered Q12hr Days 7-14

Trial Locations (1)

Pfizer Clinical Research Unit, Brussels